08:20 AM EDT, 03/20/2024 (MT Newswires) -- Mark Jeffrey DeLong, Chief Business & Strat Officer, on March 18, 2024, sold 9,913 shares in Apellis Pharmaceuticals ( APLS ) for $564,050. Following the Form 4 filing with the SEC, DeLong has control over a total of 54,693 shares of the company, with 54,693 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1492422/000112760224010605/xslF345X03/form4.xml